» Articles » PMID: 36775097

Neuroimmune Interactions with Binge Alcohol Drinking in the Cerebellum of IL-6 Transgenic Mice

Overview
Specialties Neurology
Pharmacology
Date 2023 Feb 12
PMID 36775097
Authors
Affiliations
Soon will be listed here.
Abstract

The neuroimmune system of the brain, which is comprised primarily of astrocytes and microglia, regulates a variety of homeostatic mechanisms that underlie normal brain function. Numerous conditions, including alcohol consumption, can disrupt this regulatory process by altering brain levels of neuroimmune factors. Alcohol and neuroimmune factors, such as proinflammatory cytokines IL-6 and TNF-alpha, act at similar targets in the brain, including excitatory and inhibitory synaptic transmission. Thus, alcohol-induced production of IL-6 and/or TNF-alpha could be important contributing factors to the effects of alcohol on the brain. Recent studies indicate that IL-6 plays a role in alcohol drinking and the effects of alcohol on the brain activity following the cessation of alcohol consumption (post-alcohol period), however information on these topics is limited. Here we used homozygous and heterozygous female and male transgenic mice with increased astrocyte expression of IL-6 to examined further the interactions between alcohol and IL-6 with respect to voluntary alcohol drinking, brain activity during the post-alcohol period, IL-6 signal transduction, and expression of synaptic proteins. Wildtype littermates (WT) served as controls. The transgenic mice model brain neuroimmune status with respect to IL-6 in subjects with a history of persistent alcohol use. Results showed a genotype dependent reduction in voluntary alcohol consumption in the Drinking in the Dark protocol and in frequency-dependent relationships between brain activity in EEG recordings during the post-alcohol period and alcohol consumption. IL-6, TNF-alpha, IL-6 signal transduction partners pSTAT3 and c/EBP beta, and synaptic proteins were shown to play a role in these genotypic effects.

Citing Articles

Potentiation of the depressant effect of alcohol by flunitrazepam in rats: an electrocorticographic, respiratory and electrocardiographic study.

Freitas L, Amaral A, Conceicao R, Barbosa G, Hamoy M, Barbosa A Naunyn Schmiedebergs Arch Pharmacol. 2024; 397(10):7599-7613.

PMID: 38676788 DOI: 10.1007/s00210-024-03111-w.


Impact of Elevated Brain IL-6 in Transgenic Mice on the Behavioral and Neurochemical Consequences of Chronic Alcohol Exposure.

Gruol D, Calderon D, Huitron-Resendiz S, Cates-Gatto C, Roberts A Cells. 2023; 12(18).

PMID: 37759527 PMC: 10527024. DOI: 10.3390/cells12182306.


Sex-dependent factors of alcohol and neuroimmune mechanisms.

Cruz B, Borgonetti V, Bajo M, Roberto M Neurobiol Stress. 2023; 26:100562.

PMID: 37601537 PMC: 10432974. DOI: 10.1016/j.ynstr.2023.100562.

References
1.
Perkins A, Varlinskaya E, Deak T . From adolescence to late aging: A comprehensive review of social behavior, alcohol, and neuroinflammation across the lifespan. Int Rev Neurobiol. 2019; 148:231-303. PMC: 7265136. DOI: 10.1016/bs.irn.2019.08.001. View

2.
Del Rey A, Balschun D, Wetzel W, Randolf A, Besedovsky H . A cytokine network involving brain-borne IL-1β, IL-1ra, IL-18, IL-6, and TNFα operates during long-term potentiation and learning. Brain Behav Immun. 2013; 33:15-23. DOI: 10.1016/j.bbi.2013.05.011. View

3.
Vore A, Barney T, Gano A, Varlinskaya E, Deak T . Adolescent intermittent ethanol (AIE) produces sex specific alterations in adult neuroimmune gene expression and ethanol sensitivity that are independent of ethanol metabolism. Neuropharmacology. 2021; 195:108635. PMC: 9295009. DOI: 10.1016/j.neuropharm.2021.108635. View

4.
Erickson E, Grantham E, Warden A, Harris R . Neuroimmune signaling in alcohol use disorder. Pharmacol Biochem Behav. 2018; 177:34-60. PMC: 6946054. DOI: 10.1016/j.pbb.2018.12.007. View

5.
Naro A, Pignolo L, Bruschetta D, Calabro R . What about the role of the cerebellum in music-associated functional recovery? A secondary EEG analysis of a randomized clinical trial in patients with Parkinson disease. Parkinsonism Relat Disord. 2022; 96:57-64. DOI: 10.1016/j.parkreldis.2022.02.012. View